The FDA has announced the withdrawal of specific badge drugs in Maharashtra due to the side effects of Remdesivir used for corona patients with complaints of side effects, including fever, occurring in patients using Remdesivir in Maharashtra.
Raigad District Collector Nithi Chowdhury said, “About 130 patients in 3 hospitals in Panvel taluka of Maharashtra were given the Remdesivir brand manufactured by Hetero Pharmaceuticals. In Raigad district, 510 bottles were received on April 28 and distributed to hospitals in Panvel taluka.
The drug was said to cause side effects including tremor, low blood pressure and low oxygen levels. We informed the FDA, they stopped the specific badge and the vials were withdrawn from the hospitals.
According to the Central’s protocol, Remdesivir is not a life-saving drug and is only effective between the second and ninth day after a positive test. This injection after the ninth day is useless. With this in mind, all doctors should use injections, ” The Hindu reported.
“As a precautionary measure, we have recalled vials with a specific badge after three hospitals in Pune reported side effects to their patients. If the content in the bottle has created any contamination, we will investigate it. The drug is safe and there is no need to panic, ”said Shyam Pratapwar, assistant commissioner of the Food and Drug Administration (FDA) in Pune, according to the Times of India.
“Remdesivir used 232 vials of the drug and 13 patients reported side effects. The company has announced the recall of 418 vials of unused Remdesivir injections, ”said Palghar sub-collector Surendra Navale, according to the Deccan Herald.
In this case, it is reported that a letter has been issued on behalf of Hetero by the company not to use Remdesivir drugs with the badge number HCL21013 manufactured by Hetero Pharmaceuticals.
Links :
FDA recalls batch of Remdesivir vials from Raigad district
Maharashtra: Remdesivir batch recalled by FDA after many report fever and chills
covid-19-patients-in-maharashtra-develop-side-effects-from-remdesivir
